| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 30,948,575 | 27,558,135 | 18,853,688 | | Cost of Revenue | 29,668,145 | 26,381,732 | 17,924,690 | | | Gross Profit | 1,280,430 | 1,176,403 | 928,998 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 979,060 | 807,029 | 547,538 | | Non Recurring | 6,058,067 | 90,088 | 5,026 | | Others | 135,872 | 112,317 | 37,089 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,892,569) | 166,969 | 339,345 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 77,594 | | Earnings Before Interest And Taxes | (5,892,569) | 166,969 | 416,939 | | Interest Expense | 188,369 | 101,302 | 91,986 | | Income Before Tax | (6,080,938) | 65,667 | 324,953 | | Income Tax Expense | 5,209 | 705,037 | 4,053 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,086,147) | (639,370) | 320,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 187,738 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (6,086,147) | (639,370) | 508,638 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,086,147) | ($639,370) | $508,638 |
|
1.48% Nasdaq 
Income Statement
